Avaleht › Äge lümfoblastne leukeemia › Washington
Äge lümfoblastne leukeemia kliinilised uuringud osariigis Washington
22 uuringut haiguse Äge lümfoblastne leukeemia jaoks otsivad osalejaid osariigis Washington.
Linnad osariigis Washington
Ametlik uuringutekst (inglise keeles)
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Seattle Children's, University of Washington, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
Värbamine
Vanused 1–25 · Kõik sood · Uuendatud 2. okt 2026 · NCT05621291Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- ja veel 19
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 12–78 · Kõik sood · Uuendatud 29. sept 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Seattle Children's Hospital, Seattle
VärbamineFaas 2
6 Months · Kõik sood · Uuendatud 28. sept 2026 · NCT06514794The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- ja veel 1
VärbamineFaas 1/2
Kuni 22 aastane · Kõik sood · Uuendatud 25. aug 2026 · NCT04726241Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Seattle Children's Hospital d/b/a Seattle Children's Research Institute, Seattle
VärbamineVaatlusuuring
1 Day – 17 Years · Kõik sood · Uuendatud 14. aug 2026 · NCT06274788Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. aug 2026 · NCT07224100Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
6 Months – 65 Years · Kõik sood · Uuendatud 22. juuli 2026 · NCT06013423Multicenter HomeVENT: Home Values and Experiences Navigation Track
- Seattle Childrens Hospital, Seattle
VärbamineTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. juuli 2026 · NCT06102330A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Fred Hutchinson Cancer Research Center, Seattle
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 6. juuli 2026 · NCT01351545211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 1/2
Vanused 18–75 · Kõik sood · Uuendatud 22. juuni 2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 1/2
Vanused 18–75 · Kõik sood · Uuendatud 22. juuni 2026 · NCT03670966Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2Terved vabatahtlikud oodatud
6 Months · Kõik sood · Uuendatud 29. mai 2026 · NCT04195633HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 1
Kuni 80 aastane · Kõik sood · Uuendatud 18. mai 2026 · NCT03326921Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 18. mai 2026 · NCT01790152A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1806, Seattle
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. apr 2026 · NCT06051409A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 2
Vanused 18–66 · Kõik sood · Uuendatud 17. märts 2026 · NCT06859424Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
Vanused 1–60 · Kõik sood · Uuendatud 12. märts 2026 · NCT03970096Pediatric Normative Markerless Movement Analysis
- Mary Bridge Children's Therapy Unit - Research & Movement Lab, Puyallup
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 3–25 · Kõik sood · Uuendatud 9. märts 2026 · NCT06249880Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Fred Hutchinson Cancer Research Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. nov 2025 · NCT04260022Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 15. apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Seattle Children's Hospital, Seattle
VärbamineFaas 1
Vanused 1–21 · Kõik sood · Uuendatud 6. dets 2024 · NCT05476770Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.